
    
      The primary objective of this study is to evaluate the safety and performance of the
      SinopsysÂ® Lacrimal Stent in the treatment of patients with moderate to severe chronic chronic
      rhinosinusitis via direct ethmoid sinus saline irrigation and delivery of an ophthalmic
      antibiotic/steroid drug.
    
  